-
Aspect Medical Systems (Newton, Massachusetts) reported that it has amended its product development agreement with Boston Scientific (Natick, Massachusetts) to provide a two-year extension to the period during which Boston Scientific may exercise an option to distribute sedation management technology for interventional and specialty medical procedure suites.
-
Women suffering from cardiovascular disease outnumber men, according to the American Heart Association (AHA; Dallas). And therefore it would make sense then that women must undergo more interventional procedures, right? Not true, according to a panel of experts that last month released a scientific statement calling for improvement in the treatment of female cardiovascular patients and earlier diagnosis and referral to contemporary interventional cardiovascular therapies.
-
Gary Ingenito, MD, PhD, has been named senior vice president, clinical development and regulatory affairs, for Angiotech Pharmaceuticals (Vancouver). He formerly was senior vice president of contract research organization SFBC International. Angiotech is focused on developing drug-eluting medical devices and biomaterials.
-
-
The cardiovascular sector was a focal point during healthcare investor conferences on both the East and West coasts of the U.S. in January; representatives of securities firms and medical technology companies, along with a smattering of clinicians, took a look at how med-tech performed last year and where it is headed in 2005.
-
While a festive atmosphere was building outside as the annual Mardi Gras events began, inside the huge Ernest Morial Convention Center, the approximately 3,000 attendees at the 30th annual International Stroke Conference, held here in early February under the sponsorship of the American Stroke Association (ASA; Dallas), were hearing the same old refrain from earlier meetings.
-
In what is most certainly a boon for patients and a boom for manufacturers of implantable cardioverter defibrillators (ICDs), the Centers for Medicare & Medicaid Services (CMS; Baltimore) said in late January that it would expand coverage of the devices.
-
The Cleveland Clinic (Cleveland) has been awarded a five-year, $17.22 million grant from the National Institutes of Health (NIH; Bethesda, Maryland) to advance its research into the science of heart attacks.
-
WorldHeart (Oakland, California) reported in February that it plans to acquire all of the assets of MedQuest Products (Salt Lake City), thus bringing together in complementary fashion, heart support devices that beat and those that whir.
-
LeMaitre Vascular (Burlington, Massachusetts) reported acquiring Endomed (Phoenix), a maker of endovascular stent grafts for the minimally invasive treatment of thoracic and abdominal aortic aneurysms (AAA).
